HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,850 | +8.8% | 34,455 | +12.3% | 0.00% | +33.3% |
| Q1 2024 | $2,619 | -0.2% | 30,688 | -0.0% | 0.00% | -25.0% |
| Q4 2023 | $2,625 | -51.8% | 30,702 | -49.5% | 0.00% | -50.0% |
| Q3 2023 | $5,444 | +79.0% | 60,773 | +70.1% | 0.01% | +100.0% |
| Q2 2023 | $3,041 | -41.1% | 35,721 | -42.7% | 0.00% | -42.9% |
| Q1 2023 | $5,161 | +27.4% | 62,373 | +21.1% | 0.01% | +16.7% |
| Q4 2022 | $4,050 | -99.9% | 51,493 | +2.5% | 0.01% | +20.0% |
| Q3 2022 | $3,718,000 | +14.0% | 50,219 | +0.4% | 0.01% | +25.0% |
| Q2 2022 | $3,260,000 | +6.5% | 50,017 | +3.3% | 0.00% | +33.3% |
| Q1 2022 | $3,060,000 | +19.3% | 48,409 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $2,566,000 | -22.0% | 48,371 | +3.7% | 0.00% | -25.0% |
| Q3 2021 | $3,291,000 | -21.9% | 46,624 | -26.3% | 0.00% | 0.0% |
| Q2 2021 | $4,214,000 | -45.0% | 63,233 | -8.4% | 0.00% | -50.0% |
| Q1 2021 | $7,667,000 | -15.1% | 69,064 | -9.2% | 0.01% | -20.0% |
| Q4 2020 | $9,033,000 | +24.3% | 76,064 | -8.6% | 0.01% | +11.1% |
| Q3 2020 | $7,265,000 | -3.2% | 83,264 | -0.6% | 0.01% | -10.0% |
| Q2 2020 | $7,502,000 | +40.5% | 83,768 | +56.4% | 0.01% | +25.0% |
| Q1 2020 | $5,339,000 | +1.0% | 53,568 | +16.5% | 0.01% | +33.3% |
| Q4 2019 | $5,285,000 | -32.5% | 46,000 | -25.9% | 0.01% | -40.0% |
| Q3 2019 | $7,830,000 | +23.9% | 62,075 | +18.2% | 0.01% | +25.0% |
| Q2 2019 | $6,318,000 | +35.8% | 52,500 | -1.3% | 0.01% | +33.3% |
| Q1 2019 | $4,654,000 | -23.7% | 53,200 | -12.7% | 0.01% | -33.3% |
| Q4 2018 | $6,099,000 | -18.2% | 60,955 | -6.3% | 0.01% | 0.0% |
| Q3 2018 | $7,457,000 | +22.5% | 65,080 | -4.2% | 0.01% | +12.5% |
| Q2 2018 | $6,089,000 | -18.6% | 67,900 | -33.6% | 0.01% | -11.1% |
| Q1 2018 | $7,480,000 | +25.9% | 102,247 | 0.0% | 0.01% | +28.6% |
| Q4 2017 | $5,939,000 | +128.6% | 102,247 | +76.6% | 0.01% | +133.3% |
| Q3 2017 | $2,598,000 | +13.6% | 57,900 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,286,000 | -5.5% | 57,900 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $2,419,000 | +1.5% | 59,628 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $2,383,000 | +13.9% | 59,269 | +2.6% | 0.00% | 0.0% |
| Q3 2016 | $2,092,000 | +24.9% | 57,769 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $1,675,000 | -17.1% | 57,769 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $2,021,000 | +12.4% | 57,769 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $1,798,000 | +2.7% | 55,769 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $1,751,000 | -71.2% | 54,169 | -63.2% | 0.00% | -66.7% |
| Q2 2015 | $6,087,000 | +31.6% | 147,176 | +43.0% | 0.01% | +28.6% |
| Q1 2015 | $4,624,000 | +20.0% | 102,940 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $3,852,000 | +8.6% | 102,940 | +1.4% | 0.01% | +20.0% |
| Q3 2014 | $3,546,000 | -18.6% | 101,540 | -17.8% | 0.01% | -16.7% |
| Q2 2014 | $4,358,000 | +10.5% | 123,540 | +2.1% | 0.01% | 0.0% |
| Q1 2014 | $3,945,000 | -22.6% | 121,040 | 0.0% | 0.01% | -25.0% |
| Q4 2013 | $5,099,000 | +5.6% | 121,040 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $4,827,000 | -4.7% | 121,040 | -1.2% | 0.01% | -11.1% |
| Q2 2013 | $5,067,000 | – | 122,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 538,962 | $61,927,000 | 2.21% |
| Parkman Healthcare Partners LLC | 60,250 | $6,923,000 | 2.00% |
| Bridge City Capital, LLC | 40,541 | $4,658,000 | 1.92% |
| Millrace Asset Group, Inc. | 14,665 | $1,685,000 | 1.83% |
| Nitorum Capital, L.P. | 280,586 | $32,239,000 | 1.80% |
| COOKSON PEIRCE & CO INC | 136,101 | $15,638,000 | 1.38% |
| EMERALD ADVISERS, LLC | 248,520 | $28,555,000 | 1.21% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,161 | $12,657,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,240 | $27,489,000 | 1.12% |
| Jackson Square Partners, LLC | 1,778,966 | $204,403,000 | 1.07% |